Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Stimulating the development of medicines for children 23 juli 2015Press releaseCorporatePaediatrics EU and Swiss regulators sign confidentiality arrangement 22 juli 2015NewsCorporate Pharmacovigilance Risk Assessment Committee confirms Chair and Vice-chair for new three year mandate 17 juli 2015NewsCorporatePharmacovigilance Public register of parallel distribution now available 15 juli 2015News Improving bioequivalence studies 15 juli 2015NewsCorporate FDA, European Commission and EMA reinforce collaboration to advance medicine development and evaluation 14 juli 2015NewsCorporate Call for civil society members of EMA Management Board 14 juli 2015NewsCorporate How to improve the availability of veterinary vaccines in Europe 13 juli 2015NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2015 13 juli 2015NewsHumanPharmacovigilance EMA to further clarify safety profile of human papillomavirus (HPV) vaccines 13 juli 2015Press releaseHumanPharmacovigilance 1 … 170 171 172 173 174 Page 174 of 380 175 176 177 178 … 380
Pharmacovigilance Risk Assessment Committee confirms Chair and Vice-chair for new three year mandate 17 juli 2015NewsCorporatePharmacovigilance
FDA, European Commission and EMA reinforce collaboration to advance medicine development and evaluation 14 juli 2015NewsCorporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2015 13 juli 2015NewsHumanPharmacovigilance
EMA to further clarify safety profile of human papillomavirus (HPV) vaccines 13 juli 2015Press releaseHumanPharmacovigilance